Issuer positions
1
Reporting Owner Activity for Jonathan Piazza
Form 3/4/5 issuer positions and transaction evidence for this reporting owner.
Largest position
Silverback Therapeutics, Inc.
Disclosed value
$261.9K
Recent activity
Available
- Owner position summary
-
Reported owner value
$261,878
Estimated from parsed Forms 3/4/5 when the filing discloses holding values.
Issuer count
1
Distinct issuers tied to this reporting owner in parsed SEC filings.
Largest reported position
ARS Pharmaceuticals, Inc. (SPRY)
About $261.9K reported in parsed owner filings.
Latest owner filing
04 May 2022
Most recent owner-level filing date in the parsed SEC record.
- Reported values are estimates from parsed SEC Forms 3/4/5 when the filing includes enough pricing and share data.
- Verify the source filing before treating any owner position as current.
- Location
- Seattle, WA
- SEC signature
- /s/ Jeffrey C. Pepe, Attorney-in-Fact
- Source evidence
- Open source filing history
SEC ownership signals
1 fact
Identity
1 fact
SEC filing record
1 fact
SEC evidence
1 fact
Follow Filing Activity
Follow Jonathan Piazza and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Reported issuer positions for Jonathan Piazza
SPRY
Forms 3/4/5
Silverback Therapeutics, Inc.
- Relationship
- Chief Financial Officer
- Holdings value
- $261,878
- Past year net change
- Change %
- Report period
- 02 May 2022
Insider Transactions Reported by Jonathan Piazza:
| Sym | Company | Class | Transaction | % | Reported value | Reported price | Shares | Shares after | Date | Ownership |
|---|
* indicates a reported price that failed the local validity check.